Literature DB >> 20736742

Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection.

Gerard J Nuovo1, Xin Wu, Stefano Volinia, Fengting Yan, Gianpiero di Leva, Nena Chin, Alcina F Nicol, Jinmai Jiang, Gregory Otterson, Thomas D Schmittgen, Carlo Croce.   

Abstract

Infection by the human papillomavirus (HPV) is a cause of cervical intraepithelial neoplasia (CIN) and cancer. microRNA (miRNA) in situ analysis of the transformation zone epithelia, the site of initial cervical HPV infection, showed that miRNAs let-7c, -99a, 26a, and 125b were the most abundantly expressed. In situ testing of CIN 1 showed a dramatic reduction in miR-125b expression in the koilocytes, the cytologic marker of productive HPV infection. A marked reduction in miR-125b was likewise observed in the HPV-infected cells of the condyloma acuminatum, verruca vulgaris, and epidermodysplasia verruciformis. Reverse transcriptase in situ polymerase chain reaction (PCR) showed that the pre-miRNA 125b was present in the koilocyte, suggesting direct inactivation of the mature miRNA. HEK cells transfected with only the antimiR-125b showed perinuclear halos equivalent to HPV-infected koilocytes. NIH 3T3 cells transfected with the HPV 16 full-length genome and mimetic miR-125b showed a marked reduction in viral DNA and protein synthesis by quantitative PCR and in situ-based analyses, respectively (P=0.002). Alternatively, cotransfection with anti-miR-125b and HPV 16 markedly increased HPV DNA (P=0.002). Sequence analyses showed strong homology between L2 of different HPV genotypes and miR-125b. Transfection with HPV 16 L2 resulted in a marked reduction in miR-125b levels in the NIH 3T3 cells. HPV L2-induced inactivation of miR-125b is associated with the classic cytologic changes of the koilocyte, and the exogenous application of mimetic miR-125b markedly inhibits HPV DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736742      PMCID: PMC4284817          DOI: 10.1097/PDM.0b013e3181c4daaa

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  28 in total

1.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.

Authors:  G J Nuovo; T W Plaia; S A Belinsky; S B Baylin; J G Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Detection and quantitation of HPV gene expression using real-time PCR.

Authors:  Rashmi Seth; John Rippin; Li Guo; David Jenkins
Journal:  Methods Mol Med       Date:  2005

4.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Authors:  I Martinez; A S Gardiner; K F Board; F A Monzon; R P Edwards; S A Khan
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

Review 5.  Human papillomaviruses. Applications, caveats and prevention.

Authors:  Christopher P Crum; Ross S Berkowitz
Journal:  J Reprod Med       Date:  2002-07       Impact factor: 0.142

Review 6.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

7.  A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets.

Authors:  Gerard J Nuovo; Terry S Elton; Patrick Nana-Sinkam; Stefano Volinia; Carlo M Croce; Thomas D Schmittgen
Journal:  Nat Protoc       Date:  2009-01-08       Impact factor: 13.491

8.  Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

Authors:  Hannah H Alphs; Ratish Gambhira; Balasubramanyam Karanam; Jeffrey N Roberts; Subhashini Jagu; John T Schiller; Weiguang Zeng; David C Jackson; Richard B S Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

9.  In situ detection of mature microRNAs by labeled extension on ultramer templates.

Authors:  Gerard Nuovo; Eun Joo Lee; Sean Lawler; Jakub Godlewski; Thomas Schmittgen
Journal:  Biotechniques       Date:  2009-02       Impact factor: 1.993

10.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

Authors:  M Crawford; E Brawner; K Batte; L Yu; M G Hunter; G A Otterson; G Nuovo; C B Marsh; S P Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

View more
  23 in total

1.  MicroRNA expression profiles in Kaposi's sarcoma.

Authors:  Ana Maria Catrina Ene; Ioana Borze; Mohamed Guled; Mariana Costache; Gayle Leen; Maria Sajin; Elena Ionica; Aura Chitu; Sakari Knuutila
Journal:  Pathol Oncol Res       Date:  2013-09-13       Impact factor: 3.201

2.  A baculovirus-encoded MicroRNA (miRNA) suppresses its host miRNA biogenesis by regulating the exportin-5 cofactor Ran.

Authors:  C P Singh; J Singh; J Nagaraju
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 3.  MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.

Authors:  Joana Ribeiro; Hugo Sousa
Journal:  Mol Biol Rep       Date:  2014-01-09       Impact factor: 2.316

4.  Let-7c is a Candidate Biomarker for Cervical Intraepithelial Lesions: A Pilot Study.

Authors:  Mariana Malta; Joana Ribeiro; Paula Monteiro; Joana Loureiro; Rui Medeiros; Hugo Sousa
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

Review 5.  Regulation of cellular miRNA expression by human papillomaviruses.

Authors:  Zhi-Ming Zheng; Xiaohong Wang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

Review 6.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

7.  HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.

Authors:  Bao Zang; Guojin Huang; Xiaowei Wang; Shiying Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

8.  The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methods.

Authors:  Fengting Yan; Xin Wu; Melissa Crawford; Wenrui Duan; Emily E Wilding; Li Gao; S Patrick Nana-Sinkam; Miguel A Villalona-Calero; Robert A Baiocchi; Gregory A Otterson
Journal:  Methods       Date:  2010-10-01       Impact factor: 3.608

9.  DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).

Authors:  M K Sannigrahi; Rajni Sharma; Varinder Singh; Naresh K Panda; Vidya Rattan; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2018-02-17       Impact factor: 3.396

10.  Polyphenols Could Prevent SARS-CoV-2 Infection by Modulating the Expression of miRNAs in the Host Cells.

Authors:  Dragan Milenkovic; Tatjana Ruskovska; Ana Rodriguez-Mateos; Christian Heiss
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.